Clinical Trial Update: Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating gabapentin to reduce postoperative pain medication use in bladder cancer patients undergoing radical cystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Carcinoma

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: University of Washington | Conditions: Bladder Carcinoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-06-04